Table 1.

Sensitivity of human pathogenic microbes to the new synthetic heterocyclic compounds using the hole method.

Compound	Conc. (g/mL)	Pathogens
		Aa	B	C	D	E
Tobramycin	0.010	15b	13	22	-	14
	0.005	13	11	17	-	8
2a	0.010	11	12	12	-	9
	0.005	8	10	8	-	-
2b	0.010	13	13	14	-	8
	0.005	8	8	9	-	-
2c	0.010	-	8	11	-	-
	0.005	-	-	8	-	-
2d	0.010	-	9	10	-	8
	0.005	-	-	8	-	-
3a	0.010	8	12	10	8	14
	0.005	-	9	8	-	10
3b	0.010	9	11	11	-	15
	0.005	-	10	8	-	12
3c	0.010	8	8	10	8	14
	0.005	-	-	9	-	10
3d	0.010	-	-	8	-	8
	0.005	-	-	-	-	-
3e	0.010	13	13	19	10	15
	0.005	13	-	14	9	9

^a A: Staphylococcus aureus; B: Escherichia coli; C: Candida albicans; D: local resistant Pseudomonas aeruginosa; E: reference Pseudomonas aeruginosa ATCC 27853.

^b Inhibition zone diameter measured in mm.